Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC21H18FN5O3 |
InChIKeyDMLYDMCQUBFLRS-UHFFFAOYSA-N |
CAS Registry1217272-75-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | KR | 01 Apr 2011 |